ArticleAntioxidants (Basel, Switzerland)2022

Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway.

Yiqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.